Skip to content

Clinical trials

Observational Bone Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases Phase: Observational Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20081
20102
20111
20123
20131
20144
20181
20191
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting3
Unknown status3
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.3
National Institute of Dental and Craniofacial Research (NIDCR)3
QED Therapeutics, a BridgeBio company2
Boston Medical Center1
Boston University1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Lysosomal and Rare Disorders Research and Treatment Center, Inc.1
National Institutes of Health Clinical Center (CC)1
Orthovita d/b/a Stryker1
Philips Clinical & Medical Affairs Global1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases19
Musculoskeletal Diseases4
Osteomalacia4
Hypophosphatasia3
Rickets3
Dwarfism2
Genetic Diseases, Inborn2
HIV Infections2
Mucopolysaccharidosis IV2
Muscular Diseases2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.